Targeted Axillary Dissection Does Benefit Patients with a Single Positive Node Prior to Neoadjuvant Chemotherapy

被引：0
|
作者：
Ragunathan, Janani [1 ]
Ledwidge, Serena [2 ]
机构：
[1] Queen Mary Univ London, London, England
[2] St Bartholomews Hosp, London, England
来源：
BRITISH JOURNAL OF SURGERY | 2023年 / 110卷
关键词：
D O I：
10.1093/bjs/znad258.211
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
353
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy
    Boyle, Marissa K.
    Amersi, Farin
    Chung, Alice
    Tseng, Joshua
    Giuliano, Armando E.
    ANNALS OF SURGICAL ONCOLOGY, 2025,
  • [32] Omission of axillary dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, A.
    Yasuko, U.
    Tsukahara, D.
    Jinno, H.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S29 - S29
  • [33] Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection
    Zapletal, Ondrej
    Zatecky, Jan
    Gabrielova, Lucie
    Selingerova, Iveta
    Holanek, Milos
    Burkon, Petr
    Coufal, Oldrich
    CANCERS, 2025, 17 (02)
  • [34] AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
    Banys-Paluchowski, M.
    Stickeler, E.
    de Boniface, J.
    Gentilini, O.
    Thill, M.
    Hartmann, S.
    Fasching, P. A.
    Huebner, H.
    Krawczyk, N.
    Blohmer, J. U.
    Solbach, C.
    Untch, M.
    T, Kuehn
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E93 - E94
  • [35] AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
    Banys-Paluchowski, M.
    Stickeler, E.
    de Boniface, J.
    Gentilini, O.
    Thill, M.
    Hartmann, S.
    Fasching, P. A.
    Huebner, H.
    Krawczyk, N.
    Blohmer, J-U
    Solbach, C.
    Untch, M.
    Kuehn, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E20 - E21
  • [36] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Khan, Tahsin M.
    Rossi, Alexander J.
    Suman, Vera
    Haffty, Bruce
    Hernandez, Jonathan M.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1526 - 1527
  • [37] Evaluation of the Targeted Axillary Dissection(TAD) technique in Axillary Node-Positive Breast Cancer Patients Treated with Neoadyuvant Chemotherapy(NAC)
    Camacho Falcon, M.
    De La Riva Perez, P.
    Cambil Molina, T.
    Marin Melero, I.
    Velez Medina, J.
    Bolivar Roldan, I.
    Calvo Moron, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S527 - S528
  • [38] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Tahsin M. Khan
    Alexander J. Rossi
    Vera Suman
    Bruce Haffty
    Jonathan M. Hernandez
    Judy C. Boughey
    Annals of Surgical Oncology, 2022, 29 : 1526 - 1527
  • [39] The applicability of Magseed? for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy
    Reitsamer, R.
    Peintinger, F.
    Forsthuber, E.
    Sir, A.
    BREAST, 2021, 57 : 113 - 117
  • [40] Validity of omission of axillary lymph node dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Tsukahara, Daisuke
    Jinno, Hiromitsu
    CANCER RESEARCH, 2020, 80 (04)
12345